News

Asclepius Life Sciences Co-Hosts Harvard University School of Medicine Conference on ‘Genes, Technology, and Incalculable Ethics – The Family Office of the Future’

Asclepius Life Sciences Co-Hosts Harvard University School of Medicine Conference on ‘Genes, Technology, and Incalculable Ethics – The Family Office of the Future’ April 5, 2017:  Asclepius Life Sciences Fund, L.P. was proud to be a co-host of the Harvard University School of Medicine conference on ‘Genes,

Read more

Michael J. Levas to Speak at The Superyacht Summit on March 21, 2017

Michael J. Levas to Speak at The Superyacht Summit on March 21, 2017 On March 21, 2017, Michael J. Levas will speak at the 4th Annual Superyacht Summit in West Palm Beach, Florida.  Mr. Levas will share insights on the financial markets and legislative environment in 2017. The Superyacht

Read more

Small Cap Nation Interviews Michael J. Levas on 2017 Q1 Life Sciences Industry Outlook

Small Cap Nation Interviews Michael J. Levas on 2017, Q1:  Life Sciences Industry Outlook March 10, 2017 In March, 2017, Small Cap Nation’s Jane King interviewed Michael J. Levas to discuss his outlook for the Life Sciences industry for Q1, 2017.  The interview was filmed at the NASDAQ market

Read more

NBC 6 – Small Cap Nation to Host The Family Office & Life Science Symposium at the NASDAQ MarketSite in New York on February 21, 2017

NBC 6 – Small Cap Nation to Host The Family Office & Life Science Symposium at the NASDAQ MarketSite in New York on February 21, 2017 On February 16, 2017, NBC 6 featured a press release highlighting Small Cap Nation™ (SCN), a New York based financial media and

Read more

Asclepius Life Sciences Hosts Investor Forum – January 16, 2017 | South Florida

Asclepius Life Sciences Hosts Investor Forum Investing in Life Sciences:  Distinctive Opportunities in the Public & Private Markets On January 16, 2017, Asclepius Life Sciences is proud to host a private investor forum in South Florida to discuss investment opportunities currently present within the Life Sciences sector.  The event

Read more

Small Cap Nation Features Asclepius Life Sciences

Small Cap Nation Features Asclepius Life Sciences December 16, 2016 Filmed at the NASDAQ market site in New York City, Small Cap Nation’s Jane King sat down with Michael J. Levas, Co-founder & CIO of Asclepius Life Sciences Fund, L.P. to discuss the investment fund. Small Cap Nation is a a

Read more

HFMweek | Olympian Founder Launches Biotech/Healthcare Hybrid Fund

HFMweek | Olympian Founder Launches Biotech/Healthcare Hybrid Fund Asclepius Life Sciences Fund, L.P. was featured in the November 1st edition of HFMweek (Hedge Fund Manager week). Journalist Sam Macdonald highlights the October 2016 launch of Asclepius Life Sciences as a combined hedge fund, PE and VC offering.

Read more

Michael J. Levas to Speak at 3rd Annual IDF Hedge Fund Symposium

Michael J. Levas to Speak at 3rd Annual IDF Hedge Fund Symposium Michael J. Levas will be a featured speaker at the 3rd Annual IDF Hedge Fund Symposium on November 3, 2016. Hosted by The Honorable James S. Rosebush, one of the foremost leaders in building and

Read more

Michael J. Levas to Present at ‘Best Ideas’ Hedge Fund Conference on September 22

Michael J. Levas to Present at ‘Best Ideas’ Hedge Fund Conference on September 22 On September 22, 2016, Michael J. Levas has been invited to present at the ‘Best Ideas’ Hedge Fund Conference in Miami, Florida.  Mr. Levas will speak to the convergence of trends that are creating near-term investment opportunities in

Read more

Dr. Steven Gerst – Remote Patient Monitoring Is the Driving Force Behind Telemedicine’s Impact on Healthcare Today

Dr. Steven Gerst – Remote Patient Monitoring Is the Driving Force Behind Telemedicine’s Impact on Healthcare Today Dr. Steven Gerst, Co-Founder & Principal of Asclepius Life Sciences Fund L.P. and noted Health Informatics expert, was recently featured in major publications for his insights on the growth of remote

Read more
Page 1 of 212

| Accredited Investors

The information contained in this web site has been prepared solely for accredited investors. It is for informational purposes and is not an offer to sell or purchase or a solicitation of an offer to sell or purchase any interests or shares in any of the funds managed by Asclepius Investment Strategies, LLC Such offers are made only by way of a private offering memorandum delivered to qualified investors.

| Contact

ASCLEPIUS LIFE SCIENCES FUND, L.P.
641 Lexington Avenue, Suite 1337
New York, NY 10022
Phone: (212) 634-6440
Fax: (212) 634-6480